Table 2 Demographic Characteristics of Participants
From: Abuse risks and routes of administration of different prescription opioid compounds and formulations
| Â | Entire Sample N = 59,792 | Prescription Opioid Abusers N = 8,739 | ||
|---|---|---|---|---|
Characteristic | M | SD | M | SD |
Age | 33.7 | 11.5 | 33.0 | 10.8 |
| Â | N | % | N | % |
Gender | Â | Â | Â | Â |
   Male | 40,147 | 67.1 | 5,178 | 59.3 |
   Female | 19,644 | 32.9 | 3,561 | 40.7 |
Race | Â | Â | Â | Â |
   Caucasian | 31,690 | 53.0 | 5,755 | 65.9 |
   Hispanic/Latino | 11,212 | 18.8 | 1,534 | 17.6 |
   African American | 13,063 | 21.8 | 1,092 | 12.5 |
   Native American/Alaskan Native | 3,407 | 5.7 | 301 | 3.4 |
   Asian/Pacific Islander | 415 | 0.7 | 55 | .6 |
Current treatment episode prompted by criminal justice system | 36,984 | 62.0% | 3,471 | 39.9 |